RealEC Technologies, Inc. – Trademark Portfolio
Entity Type: 03
RealEC Technologies, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include REALEC. The owner is based in Santa Ana, CA.
2510 North Red Hill Avenue, Suite 230
Santa Ana, CA 92705
Showing of trademarks Trademarks
Trademark Classifications
RealEC Technologies, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does RealEC Technologies, Inc. have?
RealEC Technologies, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.
What trademark classes does RealEC Technologies, Inc. file in?
RealEC Technologies, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are RealEC Technologies, Inc.'s most well-known trademarks?
RealEC Technologies, Inc.'s registered trademark portfolio includes well-known marks such as REALEC. These are among 1 currently registered trademark in the portfolio.
What is RealEC Technologies, Inc.'s trademark registration success rate?
RealEC Technologies, Inc. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.